EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario

Angela Du, Kaitlyn Lemay, Amit Bagga, Priya T Bhola, Pierre Antoine Brown, Samantha Colaiacovo, George S Charames, Mathieu Lemaire, Matthew B Lanktree, Laila Schenkel, Luis G Peña, Samantha Riddell und 7 weitere

Genetics in Medicine Open · 2025 · 3 · 103442

DOI: 10.1016/j.gimo.2025.103442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics in Medicine Open, 2025. Verfasst von Angela Du und 18 weiteren Autor:innen. Beteiligte Einrichtung: Provincial Genetics Program, Ontario Health, Toronto, ON, Canada. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schulich School of Medicine and Dentistry, Western University, Academic Medical Organization of Southwestern Ontario.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Genetic causes account for 10% to 20% of adult and 30% to 50% of pediatric chronic kidney disease (CKD). Patients with genetic CKD have a higher risk of progression to kidney failure. More than 500 genes are implicated in kidney disease; yet, Ontario's existing gene panel options includes fewer than 45 genes. Despite growing evidence for genetic testing in CKD care, testing is not systematically integrated into the diagnostic pathway. Standardized testing and clear eligibility criteria are needed to improve diagnosis, care, and outcomes.

Methods

In 2023, Ontario Health's Provincial Genetics Program convened a Renal Genetics Expert Group to develop standardized genetic testing criteria and evidence-based multigene panels for CKD. This initiative aims to support equitable access to high-quality genetic services and improve clinical outcomes through early, accurate diagnoses.

Results

An environmental scan of provincial, national, and international guidelines informed the development of a testing framework. Literature review and expert consensus guided the creation of eligibility criteria and panel content. Input from nephrologists, geneticists, genetic counsellors, and patients was incorporated throughout the process.

Conclusion

Standardized recommendations for genetic testing in CKD promote consistent, equitable access to diagnostics across Ontario. Careful curation of multigene panels that align with current knowledge of gene-disease associations and patient phenotypes, can help streamline testing. Integration of this framework into clinical care will strengthen collaboration between nephrology and genetics, facilitate earlier diagnosis, and support personalized management, ultimately improving outcomes for individuals with CKD.

Schlagwörter

Stichwörter der Autor:innen

Chronic kidney diseaseGenetics testingGenomic medicineImplementationNephrogenetics

Autor:innen und Institutionen

  • Provincial Genetics Program, Ontario Health, Toronto, ON, Canada.
  • Windsor Regional Hospital, Windsor, ON, Canada.
  • Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.
  • Division of Nephrology, Department of Medicine, University of Ottawa and The Ottawa Hospital, Ottawa, ON, Canada.
  • Department of Clinical Genetics, Victoria Hospital, London Health Sciences Centre, London, ON, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Förderung

  • Schulich School of Medicine and Dentistry
  • Western University
  • Academic Medical Organization of Southwestern Ontario

Zitieren

APA

Du, A., Lemay, K., Bagga, A., Bhola, P. T., Brown, P. A., Colaiacovo, S., Charames, G. S., Lemaire, M., Lanktree, M. B., Schenkel, L., Peña, L. G., Riddell, S., Watkins, N., Young, T., Yu, W., Bell, K., Kim, R. H., Connaughton, D. M., & Ontario Health Provincial Genetics Program Renal Genetics Expert Group (2025). Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario. Genetics in Medicine Open, 3, 103442. https://doi.org/10.1016/j.gimo.2025.103442

Vancouver

Du A, Lemay K, Bagga A, Bhola PT, Brown PA, Colaiacovo S, et al. Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario. Genetics in Medicine Open. 2025;3:103442. doi:10.1016/j.gimo.2025.103442

BibTeX
@article{Du2025,
  author = {Du, Angela and Lemay, Kaitlyn and Bagga, Amit and Bhola, Priya T and Brown, Pierre Antoine and Colaiacovo, Samantha and Charames, George S and Lemaire, Mathieu and Lanktree, Matthew B and Schenkel, Laila and Peña, Luis G and Riddell, Samantha and Watkins, Nicholas and Young, Ted and Yu, Wilson and Bell, Kathleen and Kim, Raymond H and Connaughton, Dervla M and Ontario Health Provincial Genetics Program Renal Genetics Expert Group, Ontario Health Provincial Genetics Program Renal Genetics Expert Group},
  title = {Framework for standardized genetic testing recommendations for chronic kidney disease in Ontario},
  journal = {Genetics in Medicine Open},
  year = {2025},
  volume = {3},
  pages = {103442},
  doi = {10.1016/j.gimo.2025.103442}
}
Kostenlos starten →